Evidence map›Paper›PMID 32698290›Full record

ArticleInternational journal of surgery case reports2020

A case of a jejunal gastrointestinal stromal tumor with significantly elevated CA19-9 levels.

Koichi Mohri, Kazuhiro Hiramatsu, Yoshihisa Shibata, Taro Aoba, Masahiro Fujii, Atsuki Arimoto, Akira Ito, Takehito Kato

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Koichi MohriDepartment of General Surgery, Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan. Electronic address: m_ri619@yahoo.co.jp.
Kazuhiro HiramatsuDepartment of General Surgery, Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan.
Yoshihisa ShibataDepartment of General Surgery, Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan.
Taro AobaDepartment of General Surgery, Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan.
Masahiro FujiiDepartment of General Surgery, Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan.
Atsuki ArimotoDepartment of General Surgery, Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan.
Akira ItoDepartment of General Surgery, Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan.
Takehito KatoDepartment of General Surgery, Toyohashi Municipal Hospital, Toyohashi, Aichi, Japan.
Toyohashi Municipal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionA gastrointestinal stromal tumor (GIST) with an elevated serum tumor marker level is very rare. We report a case of jejunal GIST associated with extremely elevated levels of serum carbohydrate antigen 19-9 (CA19-9). PRESENTATION OF CASE: A 61-year-old woman was referred to our hospital for examination of an abdominal tumor. Laboratory tests revealed extremely elevated CA19-9 levels (13,498 U/mL). Enhanced abdominal computed tomography demonstrated a well-enhanced, round 40 mm tumor. The patient underwent a jejunectomy and lymph node dissection. Based on the postoperative pathological findings, the tumor was diagnosed as a GIST. Microscopically, a solid region of the resected tumor showed negative staining for CA19-9. The serum CA19-9 level drastically decreased postoperatively. DISCUSSION: Increased proliferation of epithelial cells secondary to inflammation and ulceration of epithelia may lead to increased secretion and accumulation of CA19-9, which is consequently released into the blood circulation.

conclusionIn cases of GIST, an isolated increase of serum CA19-9 is extremely rare; but they are not necessarily associated with malignant transformation.

Indexed as

Carbohydrate antigen 19-9Gastrointestinal stromal tumourTumor marker

Identifiers

PMID32698290
PMCPMC7327853
OpenAlexW3034823076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.